接受治疗的开角型青光眼患者与健康个体视野变化率:中位25年随访研究结果
这项前瞻性纵向队列研究于1991年1月至2020年2月在医院环境中开展,纳入40例接受治疗的开角型青光眼患者和29名健康参与者,每6个月进行标准自动视野计检查。中位随访超过25年,线性混合效应模型显示青光眼患者平均敏感度变化率较健康参与者快-0.032 dB/y,但差异无统计学意义(95%CI -0.134至0.070;P=0.53),仅基线平均敏感度与变化率相关。
要点
- 中位随访25.65年,78%青光眼患者平均敏感度变化率落在健康参与者范围内(-0.20至0.15 dB/y)。
- 青光眼组平均敏感度变化率较健康组快-0.032 dB/y,但差异未达统计学显著(95%CI -0.134至0.070;P=0.53)。
- 仅基线平均敏感度与变化率相关(0.021 dB/y/dB;95%CI 0.002至0.041;P=0.03)。
核心结论
- 中位随访超过25年,接受治疗的开角型青光眼患者视野变化率与健康个体相当。
研究设计与样本
- 前瞻性纵向队列研究,1991年1月至2020年2月在医院环境中开展,纳入40例接受治疗的开角型青光眼患者和29名健康参与者,每只眼随机选取作为研究眼。
主要发现
- 青光眼患者中位随访25.65年(IQR 22.49-27.02年),健康参与者中位随访19.56年(IQR 16.19-26.21年)。
- 普通最小二乘回归分析显示,31例(78%)青光眼患者平均敏感度变化率在健康参与者范围内(即-0.20 dB/y至0.15 dB/y)。
- 线性混合效应模型显示健康参与者平均敏感度变化率为0.003 dB/y(SE 0.033;95%CI -0.062至0.068;P=0.93)。
- 青光眼患者平均敏感度变化率较健康参与者快-0.032 dB/y(SE 0.052),差异无统计学意义(95%CI -0.134至0.070;P=0.53)。
- 仅基线平均敏感度与平均敏感度变化率相关(0.021 dB/y/dB;SE 0.010;95%CI 0.002至0.041;P=0.03)。
关键数值与推荐
- 青光眼患者平均随访眼压中位数15.83 mm Hg(IQR 13.05-17.33 mm Hg),健康参与者中位数14.94 mm Hg(IQR 13.28-16.01 mm Hg),P=0.25。
- 健康参与者平均敏感度变化率范围定义为-0.20 dB/y至0.15 dB/y,78%青光眼患者变化率在此范围内。
临床怎么用
- 作者认为,这些发现可指导从业者制定管理决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Estimating the rate of glaucomatous visual field change provides practical assessment of disease progression and has implications for management decisions. OBJECTIVE: To assess the rates of visual field change in patients receiving treatment for glaucoma compared with healthy individuals over an extensive follow-up period and to quantify the impact of important covariates for these rates. DESIGN, SETTING, AND PARTICIPANTS: This prospective longitudinal cohort study was conducted in a hospital-based setting from January 1991 to February 2020. The study included 40 patients receiving treatment for open-angle glaucoma and 29 healthy participants. One eye of each participant was randomly selected as the study eye. EXPOSURES: Patients with glaucoma and healthy participants received testing with standard automated perimetry every 6 months. Individual rates of mean sensitivity change were computed using ordinary least-squares regression analysis, and linear mixed-effects modeling was used to estimate the mean rates of mean sensitivity change in the 2 groups and the impact of baseline mean sensitivity, baseline age, and follow-up intraocular pressure for rate estimates. MAIN OUTCOMES AND MEASURES: Rate of mean sensitivity change in patients with glaucoma and healthy participants. RESULTS: A total of 40 patients with glaucoma (median age, 53.07 years [IQR, 48.34-57.97 years]; 21 men [52%]) and 29 healthy participants (median age, 48.80 years [IQR, 40.40-59.07 years], 17 women [59%]) were followed up for a median of 25.65 years (IQR, 22.49-27.02 years) and 19.56 years (IQR, 16.19-26.21 years), respectively. Most participants (65 individuals [94%]) self-identified as White, with the exception of 2 patients with glaucoma (1 self-identified as Black and 1 as South Asian) and 2 healthy participants (both self-identified as South Asian). The mean follow-up intraocular pressure of patients with glaucoma (median, 15.83 mm Hg [IQR, 13.05-17.33 mm Hg]) was similar to that of healthy participants (median, 14.94 mm Hg [IQR, 13.28-16.01 mm Hg]; P = .25). In an ordinary least-squares regression analysis, 31 patients (78%) with glaucoma had rates of mean sensitivity change within the range of healthy participants (ie, between -0.20 dB/y and 0.15 dB/y). Linear mixed-effects modeling revealed that the mean (SE) rate of mean sensitivity change in healthy participants was 0.003 (0.033) dB/y (95% CI, -0.062 to 0.068; P = .93). In comparison, patients with glaucoma had a mean (SE) rate of mean sensitivity change that was -0.032 (0.052) dB/y faster, but this difference was not statistically significant (95% CI, -0.134 to 0.070; P = .53). Among covariates, only baseline mean sensitivity was associated with the rate of mean sensitivity change (mean [SE], 0.021 [0.010] dB/y/dB; 95% CI, 0.002-0.041; P = .03). CONCLUSIONS AND RELEVANCE: The results of this cohort study suggest that over a median follow-up of more than 25 years, the rate of visual field change in patients receiving treatment for glaucoma was comparable to that of healthy individuals. These findings could guide practitioners in making management decisions.
引用
- Giammaria S, Hutchison DM, Rafuse PE, et al. Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals: Findings From a Median 25-Year Follow-up. JAMA Ophthalmol. 2022. PMID: 35389449. doi:10.1001/jamaophthalmol.2022.0671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。